Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism

202137 citationslettergold Open Access

Authors

Marko Lucijanić · University Hospital Dubrava

Ivan Krečak · Polytechnics of Šibenik

Ena Sorić · University Hospital Dubrava

Martina Sedinić · University Hospital Dubrava

Anica Sabljić · University Hospital Dubrava

Lovorka Đerek · University Hospital Dubrava

Ozren Jakšić ·

Abstract

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism

Topics & Keywords

Myeloproliferative Neoplasms: Diagnosis and Treatment Hemoglobinopathies and Related Disorders Muscle and Compartmental Disorders

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Blood Cancer Journal

Volume 11, Issue 11, pp. 189-189

DOI: 10.1038/s41408-021-00585-2

Field-Weighted Citation Impact: 4.35

Command Palette

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism

Authors

Abstract

Topics & Keywords

UN Sustainable Development Goals

Publication Details